Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Interleukin-17A is not expressed by CD207(+) cells in Langerhans cell histiocytosis lesions.

Allen CE, McClain KL.

Nat Med. 2009 May;15(5):483-4; author reply 484-5. doi: 10.1038/nm0509-483. No abstract available.

2.

Neither IL-17A mRNA nor IL-17A protein are detectable in Langerhans cell histiocytosis lesions.

Peters TL, McClain KL, Allen CE.

Mol Ther. 2011 Aug;19(8):1433-9. doi: 10.1038/mt.2011.106. Epub 2011 Jun 7.

3.

Langerhans cell histiocytosis.

Camelo-Piragua S, Zambrano E, Pantanowitz L.

Ear Nose Throat J. 2010 Mar;89(3):112-3. Review. No abstract available.

PMID:
20229474
4.

Histiocytosis with mixed cell populations.

Martín JM, Jordá E, Martín-Gorgojo A, Beteta G, Monteagudo C.

J Cutan Pathol. 2016 May;43(5):456-60. doi: 10.1111/cup.12687. Epub 2016 Apr 4.

PMID:
26968131
5.

Indeterminate cell tumor: a rare dendritic neoplasm.

Rezk SA, Spagnolo DV, Brynes RK, Weiss LM.

Am J Surg Pathol. 2008 Dec;32(12):1868-76. doi: 10.1097/PAS.0b013e31818593d6.

6.

Immunocytochemical investigation of Langerin (CD207) is a valuable adjunct in the cytological diagnosis of Langerhans cell histiocytosis of the thyroid.

Wohlschlaeger J, Ebert S, Sheu SY, Schmid KW, Totsch M.

Pathol Res Pract. 2009;205(6):433-6. doi: 10.1016/j.prp.2008.12.012. Epub 2009 Feb 4.

PMID:
19195798
7.

[Clinicopathologic analysis of multisystem Langerhans cell histiocytosis].

Xu X, Liu WP, Yang QP, Zhao S, Wang WY, Liao DY, Wang XQ, Lin L, Min M.

Zhonghua Bing Li Xue Za Zhi. 2011 Aug;40(8):551-2. Chinese. No abstract available.

PMID:
22169646
8.

Progress in understanding the pathogenesis of Langerhans cell histiocytosis: back to Histiocytosis X?

Berres ML, Merad M, Allen CE.

Br J Haematol. 2015 Apr;169(1):3-13. doi: 10.1111/bjh.13247. Epub 2014 Nov 28. Review.

9.

Cell-specific gene expression in Langerhans cell histiocytosis lesions reveals a distinct profile compared with epidermal Langerhans cells.

Allen CE, Li L, Peters TL, Leung HC, Yu A, Man TK, Gurusiddappa S, Phillips MT, Hicks MJ, Gaikwad A, Merad M, McClain KL.

J Immunol. 2010 Apr 15;184(8):4557-67. doi: 10.4049/jimmunol.0902336. Epub 2010 Mar 10.

10.

[Langerhans cell histiocytosis: a clinicopathologic and immunohistochemical analysis of 258 cases].

Xu X, Liu WP, Yang QP, Wang WY, Liao DY, Zhao S, Bi CF, Lin L, Min M.

Zhonghua Bing Li Xue Za Zhi. 2012 Feb;41(2):91-6. Chinese.

PMID:
22455884
11.

Langerhans Cell Histiocytosis: Emerging Insights and Clinical Implications.

Zinn DJ, Chakraborty R, Allen CE.

Oncology (Williston Park). 2016 Feb;30(2):122-32, 139. Review.

12.

Diagnostic relevance of Langerin detection in cells from bronchoalveolar lavage of patients with pulmonary Langerhans cell histiocytosis, sarcoidosis and idiopathic pulmonary fibrosis.

Smetana K Jr, Mericka O, Saeland S, Homolka J, Brabec J, Gabius HJ.

Virchows Arch. 2004 Feb;444(2):171-4. Epub 2004 Jan 13.

PMID:
14722767
13.

Clinical spectrum of cutaneous Langerhans' cell histiocytosis mimicking various diseases.

Querings K, Starz H, Balda BR.

Acta Derm Venereol. 2006;86(1):39-43.

14.

Differentiation of Langerhans cells in Langerhans cell histiocytosis.

Geissmann F, Lepelletier Y, Fraitag S, Valladeau J, Bodemer C, Debré M, Leborgne M, Saeland S, Brousse N.

Blood. 2001 Mar 1;97(5):1241-8.

15.

Coexpression of CD1a, langerin and Birbeck's granules in Langerhans cell histiocytoses (LCH) in children: ultrastructural and immunocytochemical studies.

Dziegiel P, Dolilńska-Krajewska B, Dumańska M, Wecławek J, Jeleń M, Podhorska-Okołów M, Jagoda E, Fic M, Zabel M.

Folia Histochem Cytobiol. 2007;45(1):21-5.

16.

Revisiting Langerhans cells in paracoccidioidomycosis: expression of CD207/langerin in human cutaneous and mucosal lesions.

Pagliari C, Fernandes ER, Ferreira da Silva WL, Alves de Lima Silva A, Stegun FW, Duarte MI, Sotto MN.

Microbes Infect. 2011 Nov;13(12-13):1012-7. doi: 10.1016/j.micinf.2011.06.006. Epub 2011 Jul 1.

17.

Immunohistochemical expression of Langerin in Langerhans cell histiocytosis and non-Langerhans cell histiocytic disorders.

Lau SK, Chu PG, Weiss LM.

Am J Surg Pathol. 2008 Apr;32(4):615-9. doi: 10.1097/PAS.0b013e31815b212b.

PMID:
18277880
18.

BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups.

Berres ML, Lim KP, Peters T, Price J, Takizawa H, Salmon H, Idoyaga J, Ruzo A, Lupo PJ, Hicks MJ, Shih A, Simko SJ, Abhyankar H, Chakraborty R, Leboeuf M, Beltrão M, Lira SA, Heym KM, Bigley V, Collin M, Manz MG, McClain K, Merad M, Allen CE.

J Exp Med. 2014 Apr 7;211(4):669-83. doi: 10.1084/jem.20130977. Epub 2014 Mar 17. Erratum in: J Exp Med. 2015 Feb 9;212(2):281.

19.

Specific infiltration of langerin-positive dendritic cells in EBV-infected tonsil, Hodgkin lymphoma and nasopharyngeal carcinoma.

Braz-Silva PH, Vitale S, Butori C, Guevara N, Santini J, Magalhães M, Hofman P, Doglio A.

Int J Cancer. 2011 May 15;128(10):2501-8. doi: 10.1002/ijc.25597. Epub 2010 Oct 8.

20.

Immunohistochemical analysis of langerin in langerhans cell histiocytosis and pulmonary inflammatory and infectious diseases.

Sholl LM, Hornick JL, Pinkus JL, Pinkus GS, Padera RF.

Am J Surg Pathol. 2007 Jun;31(6):947-52.

PMID:
17527085

Supplemental Content

Support Center